Thomas Stankovich

Thomas Stankovich

Director of Finance/CFO at
ReShape Weightloss, Inc.
65 year
Health Technology
Consumer Services

Profile

Thomas Stankovich is currently Chief Financial Officer & Senior Vice President at ReShape Weightloss, Inc. since 2019.
Former roles include President, Chief Executive Officer, CFO & CAO at ReShape Lifesciences, Inc. in 2022; Chief Financial Officer & Senior Vice President at Ribapharm, Inc. from 2001 to 2003; Chief Financial Officer, Treasurer & EVP at Cobalis Corp.
from 2005 to 2006; Chief Financial Officer, Secretary & VP at Response Genetics, Inc. from 2006 to 2010; Chief Financial Officer & Secretary at Obalon Therapeutics, Inc.; Chief Financial Officer & Senior Vice President at MP Biomedicals LLC from 2003 to 2005; Chief Financial Officer & Vice President at ICN International AG from 2000 to 2001; Head-Controlling & Vice President at ICN from 1986 to 2011; and Chief Financial Officer at Vyome Holdings, Inc. Education includes undergraduate studies at California State University-Northridge.

Thomas Stankovich active positions

CompaniesPositionStart
Director of Finance/CFO 30/10/2019

Former positions of Thomas Stankovich

CompaniesPositionEnd
RESPONSE GENETICS, INC Director of Finance/CFO 02/04/2010
Director of Finance/CFO 18/12/2006
Director of Finance/CFO 01/12/2005
Director of Finance/CFO 01/01/2003
ICN International AG
Director of Finance/CFO 01/01/2001
See the detail of Thomas Stankovich's experience

Training of Thomas Stankovich

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

23

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

ICN International AG

ICN/DN Europe

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Thomas Stankovich